Literature DB >> 31600501

Zika Virus NS3 Mimics a Cellular 14-3-3-Binding Motif to Antagonize RIG-I- and MDA5-Mediated Innate Immunity.

William Riedl1, Dhiraj Acharya1, Jung-Hyun Lee1, Guanqun Liu1, Taryn Serman1, Cindy Chiang1, Ying Kai Chan2, Michael S Diamond3, Michaela U Gack4.   

Abstract

14-3-3 protein family members facilitate the translocation of RIG-I-like receptors (RLRs) to organelles that mediate downstream RLR signaling, leading to interferon production. 14-3-3ϵ promotes the cytosolic-to-mitochondrial translocation of RIG-I, while 14-3-3η facilitates MDA5 translocation to mitochondria. We show that the NS3 protein of Zika virus (ZIKV) antagonizes antiviral gene induction by RIG-I and MDA5 by binding to and sequestering the scaffold proteins 14-3-3ϵ and 14-3-3η. 14-3-3-binding is mediated by a negatively charged RLDP motif in NS3 that is conserved in ZIKV strains of African and Asian lineages and is similar to the one found in dengue and West Nile viruses. ZIKV NS3 is sufficient to inhibit the RLR-14-3-3ϵ/η interaction and to suppress antiviral signaling. Mutational perturbation of 14-3-3ϵ/η binding in a recombinant ZIKV leads to enhanced innate immune responses and impaired growth kinetics. Our study provides molecular understanding of immune evasion functions of ZIKV, which may guide vaccine and anti-flaviviral therapy development.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  RIG-I-like receptors; Zika virus; flaviviruses; innate immunity; interferon; viral immune evasion

Year:  2019        PMID: 31600501      PMCID: PMC6922055          DOI: 10.1016/j.chom.2019.09.012

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  47 in total

Review 1.  14-3-3 proteins; bringing new definitions to scaffolding.

Authors:  G Tzivion; Y H Shen; J Zhu
Journal:  Oncogene       Date:  2001-10-01       Impact factor: 9.867

Review 2.  Zika Virus Protease: An Antiviral Drug Target.

Authors:  CongBao Kang; Thomas H Keller; Dahai Luo
Journal:  Trends Microbiol       Date:  2017-08-05       Impact factor: 17.079

3.  Zika virus inhibits type-I interferon production and downstream signaling.

Authors:  Anil Kumar; Shangmei Hou; Adriana M Airo; Daniel Limonta; Valeria Mancinelli; William Branton; Christopher Power; Tom C Hobman
Journal:  EMBO Rep       Date:  2016-10-24       Impact factor: 8.807

4.  A Mouse Model of Zika Virus Pathogenesis.

Authors:  Helen M Lazear; Jennifer Govero; Amber M Smith; Derek J Platt; Estefania Fernandez; Jonathan J Miner; Michael S Diamond
Journal:  Cell Host Microbe       Date:  2016-04-05       Impact factor: 21.023

5.  TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity.

Authors:  Michaela U Gack; Young C Shin; Chul-Hyun Joo; Tomohiko Urano; Chengyu Liang; Lijun Sun; Osamu Takeuchi; Shizuo Akira; Zhijian Chen; Satoshi Inoue; Jae U Jung
Journal:  Nature       Date:  2007-04-19       Impact factor: 49.962

6.  Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling.

Authors:  Alesha Grant; Sanket S Ponia; Shashank Tripathi; Vinod Balasubramaniam; Lisa Miorin; Marion Sourisseau; Megan C Schwarz; Mari Paz Sánchez-Seco; Matthew J Evans; Sonja M Best; Adolfo García-Sastre
Journal:  Cell Host Microbe       Date:  2016-05-19       Impact factor: 21.023

7.  DENV inhibits type I IFN production in infected cells by cleaving human STING.

Authors:  Sebastian Aguirre; Ana M Maestre; Sarah Pagni; Jenish R Patel; Timothy Savage; Delia Gutman; Kevin Maringer; Dabeiba Bernal-Rubio; Reed S Shabman; Viviana Simon; Juan R Rodriguez-Madoz; Lubbertus C F Mulder; Glen N Barber; Ana Fernandez-Sesma
Journal:  PLoS Pathog       Date:  2012-10-04       Impact factor: 6.823

8.  Infection with a Brazilian isolate of Zika virus generates RIG-I stimulatory RNA and the viral NS5 protein blocks type I IFN induction and signaling.

Authors:  Jonny Hertzog; Antonio Gregorio Dias Junior; Rachel E Rigby; Claire L Donald; Alice Mayer; Erdinc Sezgin; Chaojun Song; Boquan Jin; Philip Hublitz; Christian Eggeling; Alain Kohl; Jan Rehwinkel
Journal:  Eur J Immunol       Date:  2018-04-06       Impact factor: 5.532

9.  Zika Virus Non-structural Protein 4A Blocks the RLR-MAVS Signaling.

Authors:  Jinzhu Ma; Harshada Ketkar; Tingting Geng; Emily Lo; Leilei Wang; Juemin Xi; Qiangming Sun; Zhanbo Zhu; Yudong Cui; Long Yang; Penghua Wang
Journal:  Front Microbiol       Date:  2018-06-25       Impact factor: 5.640

Review 10.  Innate immune evasion strategies of DNA and RNA viruses.

Authors:  Dia C Beachboard; Stacy M Horner
Journal:  Curr Opin Microbiol       Date:  2016-06-08       Impact factor: 7.934

View more
  42 in total

1.  DAMP-driven metabolic adaptation.

Authors:  Kirsty Minton
Journal:  Nat Rev Immunol       Date:  2020-01       Impact factor: 53.106

2.  TF protein of Sindbis virus antagonizes host type I interferon responses in a palmitoylation-dependent manner.

Authors:  K J Rogers; S Jones-Burrage; W Maury; S Mukhopadhyay
Journal:  Virology       Date:  2020-01-07       Impact factor: 3.616

3.  Spatiotemporal dynamics of innate immune signaling via RIG-I-like receptors.

Authors:  Katharina Esser-Nobis; Lauren D Hatfield; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-22       Impact factor: 11.205

4.  RNA-Seq analysis of duck embryo fibroblast cells gene expression during duck Tembusu virus infection.

Authors:  Yuhong Pan; Xuedong Wu; Wenjun Cai; Anchun Cheng; Mingshu Wang; Shun Chen; Juan Huang; Qiao Yang; Ying Wu; Di Sun; Sai Mao; Dekang Zhu; Mafeng Liu; Xinxin Zhao; Shaqiu Zhang; Qun Gao; Xumin Ou; Bin Tian; Zhongqiong Yin; Renyong Jia
Journal:  Vet Res       Date:  2022-05-18       Impact factor: 3.829

5.  Structurally Conserved Domains between Flavivirus and Alphavirus Fusion Glycoproteins Contribute to Replication and Infectious-Virion Production.

Authors:  Margarita V Rangel; Nicholas Catanzaro; Sara A Thannickal; Kelly A Crotty; Maria G Noval; Katherine E E Johnson; Elodie Ghedin; Helen M Lazear; Kenneth A Stapleford
Journal:  J Virol       Date:  2021-11-10       Impact factor: 6.549

6.  Adaptation to host cell environment during experimental evolution of Zika virus.

Authors:  Emilie Hardy; Kassian Kobert; Soheil Rastgou Talemi; Vincent Grass; Elodie Décembre; Coralie Guy; Peter V Markov; Alain Kohl; Mathilde Paris; Anja Böckmann; Sara Muñoz-González; Lee Sherry; Thomas Höfer; Bastien Boussau; Marlène Dreux
Journal:  Commun Biol       Date:  2022-10-21

7.  Henipavirus W Proteins Interact with 14-3-3 To Modulate Host Gene Expression.

Authors:  Megan R Edwards; Mikayla Hoad; Sofiya Tsimbalyuk; Andrea R Menicucci; Ilhem Messaoudi; Jade K Forwood; Christopher F Basler
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

8.  ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity.

Authors:  GuanQun Liu; Jung-Hyun Lee; Zachary M Parker; Dhiraj Acharya; Jessica J Chiang; Michiel van Gent; William Riedl; Meredith E Davis-Gardner; Effi Wies; Cindy Chiang; Michaela U Gack
Journal:  Nat Microbiol       Date:  2021-03-16       Impact factor: 17.745

9.  Zika virus employs the host antiviral RNase L protein to support replication factory assembly.

Authors:  Jillian N Whelan; Nicholas A Parenti; Joshua Hatterschide; David M Renner; Yize Li; Hanako M Reyes; Beihua Dong; Erick R Perez; Robert H Silverman; Susan R Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

10.  LAMR1 restricts Zika virus infection by attenuating the envelope protein ubiquitination.

Authors:  Dingwen Hu; Yingchong Wang; Aixin Li; Qin Li; Caifeng Wu; Muhammad Adnan Shereen; Shanyu Huang; Kailang Wu; Ying Zhu; Wenbiao Wang; Jianguo Wu
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.